BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15568310)

  • 1. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
    Chukanov VI; Kaminskaia GO; Livchane E
    Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The reserve drugs: their safety for children and adolescents].
    Panova LV; Ovsiankina ES
    Probl Tuberk Bolezn Legk; 2005; (1):27-8. PubMed ID: 15801632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of adverse reactions due to chemotherapy on life quality indices in patients with infiltrative pulmonary tuberculosis].
    Mordyk AV; Antropova VV
    Probl Tuberk Bolezn Legk; 2008; (9):44-6. PubMed ID: 19065734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis].
    Ubaĭdullaev AM; Tashpulatova FK; Kazakov KS
    Probl Tuberk; 1998; (4):23-4. PubMed ID: 9771032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
    Gergert VIa; Rusakova LI
    Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensive chemotherapy tolerance in old patients with pulmonary tuberculosis].
    Karachunskiĭ MA; Kaminskaia GO; Uvarova TE
    Probl Tuberk Bolezn Legk; 2004; (9):25-8. PubMed ID: 15532463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follow-up of antitubercular treatment].
    Gavira R; Gómez F; Otero MJ; Barrueco M; Domínguez-Gil A
    Rev Clin Esp; 1994 Sep; 194(9):677-81. PubMed ID: 7984795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse reactions of antituberculous agents, especially about its onset and duration].
    Yamada H; Yasuoka A; Sasayama K; Doutsu Y; Hayashi T; Kohno S; Yamaguchi K; Hirota M; Hara K
    Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background].
    Tashpulatova FK
    Probl Tuberk Bolezn Legk; 2003; (6):17-20. PubMed ID: 12918234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis].
    Panova LV; Ovsiankina ES
    Probl Tuberk; 2003; (1):28-30. PubMed ID: 12652980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the patients' mental status in the tolerability of antituberculous drugs].
    Mordyk AV; Briukhanova NS; Kazakov AV
    Probl Tuberk Bolezn Legk; 2009; (3):38-42. PubMed ID: 19455986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
    Panova LV; Ovsiankina ES
    Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New-onset pulmonary tuberculosis patients with schizophrenia: course and efficiency of treatment].
    Mishin VIu; Shevchuk EIu; Tsygankov BD; Losev LV
    Probl Tuberk Bolezn Legk; 2008; (6):6-10. PubMed ID: 18710046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thiopoeitins in the treatment of tuberculosis].
    Sinitsyn MV; Bogadel'nikova IV; Sokolova GB
    Probl Tuberk Bolezn Legk; 2007; (4):21-5. PubMed ID: 17657963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute pancreatitis in patients with pulmonary tuberculosis].
    Sementsov IIa
    Probl Tuberk; 2000; (2):33-5. PubMed ID: 10838907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment].
    Lysov AV; Mordyk AV; Zatvornitskiĭ VA; Kondria AV
    Probl Tuberk Bolezn Legk; 2006; (9):45-8. PubMed ID: 17128801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enzymatic parameters of the liver function in patients with active pulmonary tuberculosis and adverse reactions to chemotherapeutic drugs].
    Bondarenko VP
    Probl Tuberk; 1979 Nov; (11):37-40. PubMed ID: 530967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.